Read + Share
Amedeo Smart
Independent Medical Education
Zhao B, Xing H, Ma W. Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET Fusion. J Thorac Oncol 2023;18:e51-e52.PMID: 37087123
Email
LinkedIn
Facebook
Twitter
Privacy Policy